Investors / OKG Capital
OKG Capital
Venture capital
OKG Capital invests in and supports early-stage companies, with a focus on chronic disease therapeutics and diagnostics, particularly oncology. It works alongside founders and collaborates with pharmaceutical companies, clinical networks, and charitable foundations to advance medical innovation.
Invests inHealthcare & Biotech
In its own wordsoncologytherapeuticsdiagnosticscnsmedical imaginghealthcare
Your fit with OKG Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOKG Capital lists 12 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 56% of its companies are based in United States. It invests most often alongside Future Planet Capital, MHV and 7G BioVentures.
Counts come from funding rounds that name OKG Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not OKG Capital's whole history. Rounds on record name 2 companies; its own site lists 12. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundOKG Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 30th | 12 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 89th | 17% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Future Planet Capital | 2 |
| MHV | 2 |
| 7G BioVentures | 1 |
| Cancer Research Horizons | 1 |
| Civilization Ventures | 1 |
| Creative Destruction Lab | 1 |
| DigitalDx Ventures | 1 |
| Duke Capital Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers12100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Future Planet Capital
Compare OKG Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with OKG Capital| Date | Company | Stage |
|---|---|---|
| 29 Sept 2026 | Seed | |
| 27 May 2026 | Seed |
Round details for OKG Capital
Amounts, full round histories and every co-investor in OKG Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
12 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| The company builds innovative diagnostic and digital solutions to transform emergency care | Healthcare & Biotech | Sept 2026Seed | Page + round | |
| DeepLook Medical develops and provides an advanced imaging enhancement tool to improve image visualization and interpretation in radiology | Healthcare & Biotech | Portfolio page | ||
| Epion Therapeutics is developing a minimally-invasive treatment for ectatic corneal disease | Healthcare & Biotech | Portfolio page | ||
| Hylid Diagnostics improves the lives of millions of people with kidney disease and heart failure through a home testing and remote care platform. | Healthcare & Biotech | Portfolio page | ||
| iFAST Diagnostics develops and provides a rapid antimicrobial susceptibility test for bacterial infections | Healthcare & Biotech | May 2026Seed | Page + round | |
| InSoma Bio develops products for reconstructive plastic surgery using bio-inspired solutions that enable surgeons to use a person's own tissue instead of synthetic implants and fillers. | Healthcare & Biotech | Portfolio page | ||
| iQure Pharma is a clinical-stage biotech company developing first-in-class astrocyte-targeted therapeutics designed to restore glutamate balance in CNS disorders. | Healthcare & Biotech | Portfolio page | ||
| Lumedica specializes in developing optical imaging devices. | Healthcare & Biotech | Portfolio page | ||
| Oxford Cancer Analytics develops a platform for early cancer detection and generates evidence-based insights to support clinical decision-making in lung disease | Healthcare & Biotech | Portfolio page | ||
| Pace Healthcare Capital invests in digital health and healthcare tech companies | Healthcare & Biotech | Portfolio page | ||
| Ymmunobio AG is advancing a first-in-class program against NPTXR—a tumor-exclusive “beacon” prevalent across 17+ major solid tumors | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- okgcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 27 May 2026
- Companies checked
- 12
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get OKG Capital's profile as data
Pull OKG Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/okgcapital.com
# also
GET /v1/firms/okgcapital.com/portfolio
GET /v1/firms/okgcapital.com/coinvestors
GET /v1/firms/okgcapital.com/news